BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1139 related articles for article (PubMed ID: 19457557)

  • 21. Supramolecular architectures assembled by the interaction of purine nucleobases with metal-oxalato frameworks. Non-covalent stabilization of the 7H-adenine tautomer in the solid-state.
    García-Terán JP; Castillo O; Luque A; García-Couceiro U; Beobide G; Román P
    Dalton Trans; 2006 Feb; (7):902-11. PubMed ID: 16462950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc(II) complexes derived from pyridine-2-carbaldehyde thiosemicarbazone and (1E)-1-pyridin-2-ylethan-1-one thiosemicarbazone. Synthesis, crystal structures and antiproliferative activity of zinc(II) complexes.
    Kovala-Demertzi D; Yadav PN; Wiecek J; Skoulika S; Varadinova T; Demertzis MA
    J Inorg Biochem; 2006 Sep; 100(9):1558-67. PubMed ID: 16828164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palladium(II) complexes with R2edda-derived ligands. Part II. Synthesis, characterization and in vitro antitumoral studies of R2eddip esters and palladium(II) complexes.
    Zmejkovski BB; Kaluderović GN; Gómez-Ruiz S; Zizak Z; Steinborn D; Schmidt H; Paschke R; Juranić ZD; Sabo TJ
    Eur J Med Chem; 2009 Sep; 44(9):3452-8. PubMed ID: 19272676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, (57)Fe Mössbauer), theoretical, and biological activity studies.
    Trávnícek Z; Popa I; Cajan M; Zboril R; Krystof V; Mikulík J
    J Inorg Biochem; 2010 Apr; 104(4):405-17. PubMed ID: 20056279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of new palladium-clotrimazole and palladium-chloroquine complexes showing cytotoxicity for tumor cell lines in vitro.
    Navarro M; Peña NP; Colmenares I; González T; Arsenak M; Taylor P
    J Inorg Biochem; 2006 Jan; 100(1):152-7. PubMed ID: 16343632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA.
    Ruiz J; Cutillas N; Vicente C; Villa MD; López G; Lorenzo J; Avilés FX; Moreno V; Bautista D
    Inorg Chem; 2005 Oct; 44(21):7365-76. PubMed ID: 16212362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, crystal structure, cytotoxic activities and DNA-binding properties of new binuclear copper(II) complexes bridged by N,N'-bis(N-hydroxyethylaminoethyl)oxamide.
    Jiang M; Li YT; Wu ZY; Liu ZQ; Yan CW
    J Inorg Biochem; 2009 May; 103(5):833-44. PubMed ID: 19324417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
    Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
    J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, characterization and cytotoxicity of mixed-ligand complexes of palladium(II) with 2, 2'-biquinoline/1, 4-diaminobutane and 4-toluenesulfonyl-L-amino acid dianion.
    Zhang J; Li L; Ma L; Zhang F; Zhang Z; Wang S
    Eur J Med Chem; 2011 Nov; 46(11):5711-6. PubMed ID: 21907465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ni(II)/H(2)O(2) reactivity in bis[(pyridin-2-yl)methyl]amine tridentate ligand system. aromatic hydroxylation reaction by bis(mu-oxo)dinickel(III) complex.
    Kunishita A; Doi Y; Kubo M; Ogura T; Sugimoto H; Itoh S
    Inorg Chem; 2009 Jun; 48(11):4997-5004. PubMed ID: 19374371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platinum(II) oxalato complexes involving adenosine-based N-donor ligands: synthesis, characterization and cytotoxicity evaluation.
    Starha P; Popa I; Trávníček Z
    Molecules; 2014 Mar; 19(3):3832-47. PubMed ID: 24662093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anionic carbonato and oxalato cobalt(III) nitrogen mustard complexes.
    Craig PR; Brothers PJ; Clark GR; Wilson WR; Denny WA; Ware DC
    Dalton Trans; 2004 Feb; (4):611-8. PubMed ID: 15252524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three new Cu(II) and Cd(II) complexes with 3-(2-pyridyl)pyrazole-based ligand: syntheses, crystal structures, and evaluations for bioactivities.
    Chen R; Liu CS; Zhang H; Guo Y; Bu XH; Yang M
    J Inorg Biochem; 2007 Mar; 101(3):412-21. PubMed ID: 17222454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
    Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
    J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, X-ray structures and cytotoxic activity of platinum(II), palladium(II) and copper(II) complexes with chelating ligands.
    Budzisz E; Miernicka M; Lorenz IP; Mayer P; Balcerczak E; Krajewska U; Rozalski M
    Eur J Med Chem; 2010 Jun; 45(6):2613-21. PubMed ID: 20303625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: synthesis, characterization and in vitro antitumoral activity against chronic lymphocytic leukemia (CLL) cells.
    Vujić JM; Cvijović M; Kaluderović GN; Milovanović M; Zmejkovski BB; Volarević V; Arsenijević N; Sabo TJ; Trifunović SR
    Eur J Med Chem; 2010 Sep; 45(9):3601-6. PubMed ID: 20570025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation.
    Matović ZD; Mrkalić E; Bogdanović G; Kojić V; Meetsma A; Jelić R
    J Inorg Biochem; 2013 Apr; 121():134-44. PubMed ID: 23376555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, DNA interaction, and cytotoxicity of novel Pd(II) and Pt(II) complexes.
    Gao E; Liu F; Zhu M; Wang L; Huang Y; Liu H; Ma S; Shi Q; Wang N
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):557-64. PubMed ID: 20038273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.